Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYMBanks - Regional
+$0.15 today
- Market cap
- $12.16B
- Beta
- 0.76
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$2.54
Volume 5.80M
Average 4.76M
CHYM Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Chime Financial, Inc. Class A Common StockNASDAQ: CHYM
Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026
Stock-based compensation outflow grows to $69.4M
Q2 FY2026 stock-based compensation was $69.4M, compared with $0 a year earlier. Trailing-twelve-month stock-based compensation was $290.8M. Over 3 fiscal years it compounded at +235.5% a year.
Context
- Stock-based compensation amounted to 49.0% of revenue in FY2025, up 47.2 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly stock-based compensation holds near $69.4M or moves back toward the trailing-twelve-month quarterly average of $72.7M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 1.07B USD
- Year-over-year change
- +3488.2%
- 3-year CAGR
- +235.5%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.07B | +3488.2% |
| FY2024 | 2024-12-31 | 29.85M | +14.6% |
| FY2023 | 2023-12-31 | 26.04M | -8.2% |
| FY2022 | 2022-12-31 | 28.35M | — |
Stock-Based Compensation vs competitors
How CHYM compares with its peers on the latest reported figures
- Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
- Stock-based compensation amounts to 12.3% of revenue for CHYM, versus a peer median of 1.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1B USD | -9.2% | -7.4% | 2.9% | |
| LTM Jun 2026 | $615M USD | +7.7% | +26.5% | 1.8% | |
| LTM Sep 2026 | $394.13M USD | +53.8% | +2.4% | 1.9% | |
| LTM Jun 2026 | $290.8M USD | — | +235.5% | 12.3% | |
| LTM Jun 2026 | ¥167M JPY | — | — | 0.0% | |
| LTM Jun 2026 | $92.46M USD | -42.4% | -2.0% | 0.9% | |
| LTM Jun 2026 | $37.55M USD | -4.4% | -9.7% | 5.8% | |
| Peer median (excluding CHYM) | — | -4.4% | -2.0% | 1.8% | |
Competitors are the stored peer set for CHYM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Net Income | (470.25M) | (203.2M) | (25.34M) | (1.01B) |
| Depreciation & Amortization | 7.3M | 12.94M | 25.37M | 30M |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 28.35M | 26.04M | 29.85M | 1.07B |
| Change in Working Capital | (158.94M) | (136.73M) | (104.23M) | (234.32M) |
| Accounts Receivables | (29.28M) | (53.34M) | (40.31M) | (42.96M) |
| Inventory | 0 | 0 | 0 | 0 |
| Accounts Payables | (5.96M) | 1.35M | 13.7M | 2.83M |
| Other Working Capital | (123.7M) | (84.74M) | (77.63M) | (194.19M) |
| Other Non-Cash Items | 159.41M | 144.36M | 138.5M | 196.14M |
| Operating Cash Flow | (434.13M) | (156.59M) | 64.14M | 52.78M |
| Capital Expenditures | (72.91M) | (27.82M) | (14.47M) | (19.89M) |
| Acquisitions (Net) | 0 | 0 | (13.34M) | 0 |
| Purchases of Investments | (426.71M) | (610.67M) | (497.58M) | (5.68B) |
| Sales of Investments | 650.16M | 805.5M | 701.49M | 521.21M |
| Other Investing Activities | (24.19M) | (17.31M) | (140.1M) | 4.88B |
| Investing Cash Flow | 150.54M | 167.01M | 45.66M | (289.69M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 795.75M |
| Common Stock Repurchased | (508K) | (61K) | (950K) | (77.54M) |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.53M | 903K | 1.41M | (350.54M) |
| Financing Cash Flow | 1.02M | 842K | 456K | 367.67M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | (282.57M) | 11.26M | 110.26M | 130.76M |
| Free Cash Flow | (507.05M) | (184.41M) | 49.67M | 32.89M |
Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYM
Intrinsic Alpha fair value
Locked
Current Price
$32.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.